Center for Financial Planning’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10
| Closed | -$10.5K | – | 598 |
|
|
2024
Q2 | $10.5K | Hold |
10
| – | – | ﹤0.01% | 392 |
|
|
2024
Q1 | $9.63K | Hold |
10
| – | – | ﹤0.01% | 410 |
|
|
2023
Q4 | $8.78K | Hold |
10
| – | – | ﹤0.01% | 382 |
|
|
2023
Q3 | $8.23K | Hold |
10
| – | – | ﹤0.01% | 376 |
|
|
2023
Q2 | $7.19K | Hold |
10
| – | – | ﹤0.01% | 418 |
|
|
2023
Q1 | $8.22K | Hold |
10
| – | – | ﹤0.01% | 379 |
|
|
2022
Q4 | $7.22K | Hold |
10
| – | – | ﹤0.01% | 387 |
|
|
2022
Q3 | $7K | Sell |
10
-1
| -9% | -$700 | ﹤0.01% | 394 |
|
|
2022
Q2 | $7K | Buy |
11
+10
| +1,000% | +$6.36K | ﹤0.01% | 399 |
|
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 517 |
|
|
2021
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 523 |
|
|
2020
Q2 | – | Sell |
-10
| Closed | -$5K | – | 540 |
|
|
2020
Q1 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 416 |
|